診療科・部門

トップページ診療科・部門呼吸器外科部研究実績

研究実績

令和4年3月改訂

海外学会や英文論文を積極的に発表しています。

2020

  1. Primary pneumonectomy, pneumonectomy after induction therapy, and salvage pneumonectomy: a comparison of surgical and prognostic outcomes.Sakakura N, Mizuno T, Kuroda H, Sakao Y.J Thorac Dis. 2020 May;12(5):2672-2682. doi: 10.21037/jtd.2020年03月19日.
  2. The cranial-side parietal pleura pick-up method and the edge closure technique as a closure method for open thoracotomy.Sakakura N, Kuroda H.J Thorac Dis. 2020 Sep;12(9):5053-5055. doi: 10.21037/jtd-20-1212.
  3. Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma.Matsui T, Sakakura N, Koyama S, Nakanishi K, Sasaki E, Kato S, Hosoda W, Murakami Y, Kuroda H, Yatabe Y.Ann Thorac Surg. 2020 Nov 23:S0003-4975(20)32001-4. doi: 10.1016/j.athoracsur.2020年09月04日2. Online ahead of print.
  4. Clinical adjustability of radiological tools in patients with surgically resected cT1N0-staged non-small-cell lung cancer from the long-term survival evaluation.Kuroda H, Nakada T, Oya Y, Takahashi Y, Matsusita H, Sakakura N.J Thorac Dis. 2020 Nov;12(11):6655-6662. doi: 10.21037/jtd-20-1610.
  5. Computed tomography and positron emission tomography-staged cN0 non-small cell lung cancer. Kuroda H, Nakada T, Oya Y, Takahashi Y, Shirai S, Matsui T, Nakanishi K, Matsushita H, Sakakura N. Video-assist Thorac Surg 2020 | http://dx.doi.org/10.21037/vats.2020年04月01日
  6. The impact of same-day chest drain removal on pulmonary function after thoracoscopic lobectomy.Nakada T, Shirai S, Oya Y, Takahashi Y, Sakakura N, Ohtsuka T, Kuroda H.Gen Thorac Cardiovasc Surg. 2020 Oct 29. doi: 10.1007/s11748-020-01516-x. Online ahead of print.
  7. Efficacy of Xenon Light With Indocyanine Green for Intersegmental Visibility in Thoracoscopic Segmentectomy.Matsui T, Takahashi Y, Nakada T, Matsushita H, Oya Y, Sakakura N, Kuroda H.J Surg Res. 2020 Dec 3;259:39-46. doi: 10.1016/j.jss.2020年11月02日8. Online ahead of print.
  8. Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement.Oya Y,?Kuroda H, Nakada T, Takahashi Y, Sakakura N, Hida T.Int J Mol Sci. 2020 Apr 9;21(7):2623. doi: 10.3390/ijms21072623.
  9. Tumor Spread Through Air Spaces Is a Predictor of Occult Lymph Node Metastasis in Clinical Stage IA Lung Adenocarcinoma. Vaghjiani RG, Takahashi Y, Eguchi T, Lu S, Kameda K, Tano Z, Dozier J, Tan KS, Jones DR, Travis WD, Adusumilli PS. J Thorac Oncol. 2020 May;15(5):792-802. doi: 10.1016/j.jtho.2020.01.008. Epub 2020 Jan 30. PMID: 32007599; PMCID: PMC7199202.
  10. Negative reactions of BRAF mutation-specific immunohistochemistry to non-V600E mutations of BRAF.Seto K, Haneda M, Masago K, Fujita S, Kato S, Sasaki E, Hosoda W, Murakami Y, Kuroda H, Horio Y, Hida T, Okubo K, Yatabe Y.Pathol Int. 2020 May;70(5):253-261. doi: 10.1111/pin.12903. Epub 2020 Jan 23.
  11. Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patients.Seto K, Masago K, Fujita S, Haneda M, Horio Y, Hida T, Kuroda H, Hosoda W, Okubo KI.Thorac Cancer. 2020 Jul;11(7):1827-1834. doi: 10.1111/1759-7714.13460. Epub 2020 May 5.
  12. Clinical outcomes and Techniques for Radiofrequency ablation of lung tumor smaller than 1 cm. Hasegawa T, Sato Y, Kuroda H, Chatani S, Murata S, Yamaura H, Kato M, Onaya H, Inaba Y. Interventional Radiology 2020; 5: 94-102.
  13. Comparison of radiopaque dye materials for localization of pulmonary nodules before video-assisted thoracic surgery.Hasegawa T, Kuroda H, Chatani S, Furuya Y, Sato Y, Iwamasa H, Asai T, Yashiro H, Matsushima S, Inaba Y.J Thorac Dis. 2020 May;12(5):2070-2076. doi: 10.21037/jtd-19-4057.
  14. Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer.Kagawa Y, Furuta H, Uemura T, Watanabe N, Shimizu J, Horio Y, Kuroda H, Inaba Y, Kodaira T, Masago K, Fujita S, Niimi A, Hida T. Cancer Sci. 2020 Dec;111(12):4442-4452. doi: 10.1111/cas.14605. Epub 2020 Oct 31.

2019

  1. Lymph node dissection in the left upper lobe: clinical outcomes and surgical techniques in Japan. Kuroda H, Sugita Y, Nakanishi K, Sakao Y. Mdeiastinum 2019. : http://dx.doi.org/10.21037/med.2019年04月04日
  2. Presurgical heterogeneity of lung 18FDG-PET uptake predicts acute exacerbation of interstitial lung disease following pulmonary resection in patients with smoke exposures Kuroda H, Sugita Y, Oya Y, Takahashi Y, Nakanishi K, Sakakura N, Sakao Y, Iwata H, Hida T. Journal of Surgical Oncology doi: 10.31487/j.JSO.2019年02月08日
  3. Favorable clinical application for segmental bronchial closure based on experiment results. Kuroda H, Sugita Y, Nakanishi K, Oya Y, Sakakura N, Sakao Y.J Thorac Dis. 2019 Jun;11(6):2267-2273. doi: 10.21037/jtd.2019年06月18日.
  4. Is skeletal muscle mass an optimal marker for postoperative outcomes in lung cancer patients Takahashi Y, Nakada T, Sakakura N, Kuroda H. J Thorac Dis. 2019; 11(12): 5643-5645. doi: 10.21037/jtd.2019年11月21日.
  5. Challenges for real-time intraoperative diagnosis of high risk histology in lung adenocarcinoma: A necessity for sublobar resection. Takahashi Y, Kuroda H, Oya Y, Matsutani N, Matsushita H, Kawamura M.Thorac Cancer. 2019 Aug;10(8):1663-1668. doi: 10.1111/1759-7714.13133. Epub 2019 Jul 9.
  6. Salvage surgery for small cell lung cancer after chemoradiotherapy. Nakanishi K, Mizuno T, Sakakura N, Kuroda H,Shimizu J, Hida T, Yatabe Y, Sakao Y.Jpn J Clin Oncol. 2019 Apr 1;49(4):389-392. doi: 10.1093/jjco/hyz010.
  7. Clinicopathological Features, Surgical Outcomes, Oncogenic Status and PD-L1 Expression of Pulmonary Pleomorphic Carcinoma. Nakanishi K, Sakakura N, Matsui T, Ueno H, Nakada T, Oya Y, Shimizu J, Hida T, Hosoda W,?Kuroda H. Anticancer Res. 2019 Oct;39(10):5789-5795. doi: 10.21873/anticanres.13782.
  8. Thoracoscopic lobectomy using indocyanine green fluorescence to detect the interlobar fissure in a patient with displaced B3 and absence of fissure: A case report. Nakanishi K, Kuroda H, Nakada T, Ueno H, Sakakura N.Thorac Cancer. 2019 Jul;10(7):1654-1656. doi: 10.1111/1759-7714.13104. Epub 2019 Jun 19.
  9. The Utility of Indigo Carmine and Lipiodol Mixture for Preoperative Pulmonary Nodule Localization before Video-Assisted Thoracic Surgery. Hasegawa T,?Kuroda H, Sato Y, Matsuo K, Sakata S, Yashiro H, Sakakura N, Mizuno T, Arimura T, Yamaura H, Murata S, Imai Y, Sakao Y, Inaba Y.J Vasc Interv Radiol. 2019 Mar;30(3):446-452. doi: 10.1016/j.jvir.2018年08月02日4.
  10. Simultaneous resections of left lung cancer and esophageal schwannoma using video-assisted thoracoscopic surgery: A case report. An B, Abe T, Uemura N, Higaki E, Hosoi T, Kuroda H, Matsui T, Ishihara M, Kurita Y, Yatabe Y, Shimizu Y.Asian J Endosc Surg. 2019 Jul;12(3):348-353. doi: 10.1111/ases.12643. Epub 2018 Aug 30.

2018

  1. Kuroda H, Sugita Y, Ohya Y, Yoshida T, Arimura T, Sakakura N, Hida T, Yatabe Y, Sakao Y. Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients. Cancer Manag Res. 2018 Dec 20;11時10分7-115. doi: 10.2147/CMAR.S180757. eCollection 2019.
  2. Kuroda H, Yoshida T, Arimura T, Mizuno T, Sakakura N, Yatabe Y, Sakao Y. Contribution of smoking habit to the prognosis of stage I KRAS-mutated non-small cell lung cancer. Cancer Biomark. 2018;23(3):419-426. doi: 10.3233/CBM-181483.
  3. Kuroda H, Sakao Y. Analgesic management after thoracoscopic surgery: recent studies and our experience. J Thorac Dis. 2018 Apr;10(Suppl 9):S1050-S1054. doi: 10.21037/jtd.2018.04.34. No abstract available.
  4. Kuroda H, Yoshida T, Arimura T, Mizuno T, Sakakura N, Sakao Y. Novel development of Spectra-A using indocyanine green for segmental boundary visibility in thoracoscopic segmentectomy. J Surg Res. 2018 Jul;227:228-233. doi: 10.1016/j.jss.2018年02月01日7. Epub 2018 Mar 20.
  5. Seto K, Kuroda H, Yoshida T, Sakata S, Mizuno T, Sakakura N, Hida T, Yatabe Y, Sakao Y. Higher frequency of occult lymph node metastasis in clinical N0 pulmonary adenocarcinoma with ALK rearrangement. Cancer Manag Res. 2018 Jul 18;10:2117-2124. doi: 10.2147/CMAR.S147569. eCollection 2018.
  6. Sakakura N, Mizuno T, Kuroda H, Arimura T, Yatabe Y, Yoshimura K, Sakao Y. The eighth TNM classification system for lung cancer: A consideration based on the degree of pleural invasion and involved neighboring structures. Lung Cancer. 2018 Apr;118:134-138. doi: 10.1016/j.lungcan.2018.02.009. Epub 2018 Feb 22.
  7. Sakakura N, Mizuno T, Arimura T, Kuroda H, Sakao Y. Design variations in vertical muscle-sparing thoracotomy. J Thorac Dis. 2018 Aug;10(8):5115-5119. doi: 10.21037/jtd.2018年07月10日0. No abstract available.
  8. Dejima H, Kuroda H, Seto K, Sakata S, Arimura T, Mizuno T, Sakakura N, Sakao Y. Two cases of combined thoracoscopy and open chest surgery for locally advanced lung carcinoma. J Thorac Dis. 2018 Feb;10(2):1138-1143. doi: 10.21037/jtd.2017年12月13日2.
  9. Shozo Sakata, Tetsuya Mizuno, Hitoshi Dejima, Takaaki Arimura, Hiroaki Kuroda, Noriaki Sakakura, Yasushi Yatabe, Yukinori Sakao. A case of second primary lung cancer diagnosed by surgical resection at salvage setting. International Cancer Conference Journal 2018. 7(3): 84-86.
  10. Dejima H, Nakanishi H, Kuroda H, Yoshimura M, Sakakura N, Ueda N, Ohta Y, Tanaka R, Mori S, Yoshida T, Hida T, Sawabata N, Yatabe Y, Sakao Y. Detection of abundant megakaryocytes in pulmonary artery blood in lung cancer patients using a microfluidic platform. Lung Cancer. 2018 Nov;125:128-135. doi: 10.1016/j.lungcan.2018年09月01日1. Epub 2018 Sep 16.
  11. Matsui T, Mizuno T, Kuroda H, Sakakura N, Arimura T, Yatabe Y, Sakao Y. Spontaneous regression of lung squamous cell carcinoma with synchronous mediastinal progression: A case report. Thorac Cancer. 2018 Dec;9(12):1778-1781. doi: 10.1111/1759-7714.12892. Epub 2018 Oct 11.
  12. Mizuno T, Arimura T, Kuroda H, Sakakura N, Yatabe Y, Sakao Y. Current outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer. J Thorac Dis. 2018 Mar;10(3):1788-1796. doi: 10.21037/jtd.2018年01月14日8.
  13. Dejima H, Nakanishi H, Kuroda H, Yoshimura M, Sakakura N, Ueda N, Ohta Y, Tanaka R, Mori S, Yoshida T, Hida T, Sawabata N, Yatabe Y, Sakao Y. Detection of abundant megakaryocytes in pulmonary artery blood in lung cancer patients using a microfluidic platform. Lung Cancer. 2018 Nov;125:128-135. doi: 10.1016/j.lungcan.2018年09月01日1. Epub 2018 Sep 16.
  14. Oya Y, Yoshida T, Uemura T, Murakami Y, Inaba Y, Hida T. Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement-positive non-small cell lung cancer: A case report. Oncol Lett. 2018 Oct;16(4):4219-4222. doi: 10.3892/ol.2018.9158. Epub 2018 Jul 17.
  15. Furuta H, Uemura T, Yoshida T, Kobara M, Yamaguchi T, Watanabe N, Shimizu J, Horio Y, Kuroda H, Sakao Y, Yatabe Y, Hida T. Efficacy and Safety Data of Osimertinib in Elderly Patients with NSCLC Who Harbor the EGFR T790M Mutation After Failure of Initial EGFR-TKI Treatment. Anticancer Res. 2018 Sep;38(9):5231-5237. doi: 10.21873/anticanres.12847.
  16. An B, Abe T, Uemura N, Higaki E, Hosoi T, Kuroda H, Matsui T, Ishihara M, Kurita Y, Yatabe Y, Shimizu Y. Simultaneous resections of left lung cancer and esophageal schwannoma using video-assisted thoracoscopic surgery: A case report. Asian J Endosc Surg. 2018 Aug 30. doi: 10.1111/ases.12643. [Epub ahead of print]
  17. Tanaka H, Hijioka S, Iwaya H, Mizuno N, Kuwahara T, Okuno N, Ito A, Kuraoka N, Matsumoto S, Obata M, Kurita Y, Yasuda M, Shimizu Y, Kuroda H, Sato Y, Haneda M, Sasaki E, Yatabe Y, Hara K. Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy. Intern Med. 2018 Dec 15;57(24):3537-3543. doi: 10.2169/internalmedicine.1243-18. Epub 2018 Aug 10.
  18. Analgesic management after thoracoscopic surgery: recent studies and our experience. Kuroda H, Sakao Y. J Thorac Dis. 2018 Apr;10(Suppl 9):S1050-S1054. doi: 10.21037/jtd.2018.04.34. No abstract available.
  19. Novel development of Spectra-A using indocyanine green for segmental boundary visibility in thoracoscopic segmentectomy. Kuroda H, Yoshida T, Arimura T, Mizuno T, Sakakura N, Sakao Y. J Surg Res. 2018 Jul;227:228-233. doi: 10.1016/j.jss.2018年02月01日7. Epub 2018 Mar 20.
  20. Higher frequency of occult lymph node metastasis in clinical N0 pulmonary adenocarcinoma with ALK rearrangement Seto T*, Kuroda H, Dejima H, Mizumo T, Sakakura N, Yatabe Y, Sakao Y. Cancer Management and Research 2018. Ahead of print
  21. The eighth TNM classification system for lung cancer. A consideration based on the degree of pleral invasion and involved neighboring structures Sakakura N, Mizuno T, Kuroda H, Arimura T, Yatabe Y, Yoshimura K, Sakao Y. Lung Cancer. 2018 Apr;118:134-138. doi: 10.1016/j.lungcan.2018.02.009. Epub 2018 Feb 22.
  22. Current outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer. Mizuno T, Arimura T, Kuroda H, Sakakura N, Yatabe Y, Sakao Y. J Thorac Dis. 2018 Mar;10(3):1788-1796. doi: 10.21037/jtd.2018年01月14日8.
  23. Two cases of combined thoracoscopy and open chest surgery for locally advanced lung carcimona. Dejima H, Kuroda H, Seto K, Sakata S, Arimura T, Mizuno T, Sakakura N, Sakao Y. J Thorac Dis. 2018 Feb;10(2):1138-1143. doi: 10.21037/jtd.2017年12月13日2.
  24. Fibrolamellar hepatocellular carcinoma with multiple lung metastases treated with multidisciplinary therapy. Tanaka H, Hijioka S, Mizuono N, Kuwahara T, Okuno N, Ito A, Kuraoka N, Matsumoto S, Kurita Y, Yasuda M, Shimizu Y, Kuroda H, Sato Y, Haneda M, Sasaki E, Yatabe Y, Hara K. 2018. Internal Medicine. Accept.